During the past decade, Kenneth R. Beer, M.D., PA conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
2013-12-01
2016-08-01
Completed
224
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kenneth R. Beer, M.D., PA" #1 sponsor was "Kenneth Beer" with 3 trials, followed by "Beer, Kenneth R., M.D., PA" with 2 trials
sponsored, "Endo Pharmaceuticals" with 1 trials sponsored, "Galderma R&D" with 1 trials sponsored and "Genentech, Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kenneth R. Beer, M.D., PA"
#1 collaborator was "Allergan" with 2 trials as a collaborator and "Medicis Pharmaceutical Corporation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kenneth R. Beer, M.D., PA
According to Clinical.Site data, the most researched conditions in "Kenneth R. Beer, M.D., PA" are
"Basal Cell Carcinoma" (2 trials), "Acne Vulgaris" (1 trials), "Adiposity" (1 trials), "Brow Ptosis" (1 trials) and "Edematous Fibrosclerotic Panniculopathy (EFP)" (1 trials). Many other conditions were trialed in "Kenneth R. Beer, M.D., PA" in a lesser frequency.
Clinical Trials Intervention Types at Kenneth R. Beer, M.D., PA
Most popular intervention types in "Kenneth R. Beer, M.D., PA" are "Drug" (8 trials), "Device" (3 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dysport" (2 trials), "Placebo" (2 trials), "ATX-101" (1 trials), "CLS001 Topical Gel" (1 trials) and "CLS001 Topical Gel Vehicle" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kenneth R. Beer, M.D., PA
The vast majority of trials in "Kenneth R. Beer, M.D., PA" are
11 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Kenneth R. Beer, M.D., PA
Currently, there are NaN active trials in "Kenneth R. Beer, M.D., PA".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Kenneth R. Beer, M.D., PA,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kenneth R. Beer, M.D., PA, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 2 trials that are defined as “Not Applicable".